Binh Dinh Pharmaceutical and Medical Equipment JSC (VN:DBD) — Market Cap & Net Worth
Market Cap & Net Worth: Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD)
Binh Dinh Pharmaceutical and Medical Equipment JSC (VN:DBD) has a market capitalization of $179.32 Million (₫4.72 Trillion) as of June 17, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #17078 globally and #107 in its home market, demonstrating a 1.83% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Binh Dinh Pharmaceutical and Medical Equipment JSC's stock price ₫49950.00 by its total outstanding shares 94489262 (94.49 Million). Review DBD current and long-term liabilities to assess the company's total debt and financial obligations.
Binh Dinh Pharmaceutical and Medical Equipment JSC Market Cap History: 2018 to 2026
Binh Dinh Pharmaceutical and Medical Equipment JSC's market capitalization history from 2018 to 2026. Data shows growth from $69.73 Million to $179.32 Million (10.09% CAGR).
Binh Dinh Pharmaceutical and Medical Equipment JSC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Binh Dinh Pharmaceutical and Medical Equipment JSC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Binh Dinh Pharmaceutical and Medical Equipment JSC's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Binh Dinh Pharmaceutical and Medical Equipment JSC's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $90.46 Million | $1.26 Trillion | $157.86 Billion | 0.00x | 0.00x |
| 2021 | $108.91 Million | $1.56 Trillion | $189.12 Billion | 0.00x | 0.00x |
| 2022 | $107.61 Million | $1.55 Trillion | $243.56 Billion | 0.00x | 0.00x |
| 2023 | $155.66 Million | $1.65 Trillion | $269.05 Billion | 0.00x | 0.00x |
| 2024 | $206.78 Million | $1.73 Trillion | $275.18 Billion | 0.00x | 0.00x |
| 2025 | $175.19 Million | $1.87 Trillion | $291.94 Billion | 0.00x | 0.00x |
Competitor Companies of DBD by Market Capitalization
Companies near Binh Dinh Pharmaceutical and Medical Equipment JSC in the global market cap rankings as of June 17, 2026.
Key companies related to Binh Dinh Pharmaceutical and Medical Equipment JSC by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #561 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.22 |
| #624 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.20 Billion | CN¥47.35 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
Binh Dinh Pharmaceutical and Medical Equipment JSC Historical Marketcap From 2018 to 2026
Between 2018 and today, Binh Dinh Pharmaceutical and Medical Equipment JSC's market cap moved from $69.73 Million to $ 179.32 Million, with a yearly change of 10.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₫179.32 Million | +2.36% |
| 2025 | ₫175.19 Million | -15.28% |
| 2024 | ₫206.78 Million | +32.84% |
| 2023 | ₫155.66 Million | +44.65% |
| 2022 | ₫107.61 Million | -1.18% |
| 2021 | ₫108.91 Million | +20.39% |
| 2020 | ₫90.46 Million | -7.81% |
| 2019 | ₫98.13 Million | +40.72% |
| 2018 | ₫69.73 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Binh Dinh Pharmaceutical and Medical Equipment JSC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $179.32 Million USD |
| MoneyControl | $179.32 Million USD |
| MarketWatch | $179.32 Million USD |
| marketcap.company | $179.32 Million USD |
| Reuters | $179.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Binh Dinh Pharmaceutical and Medical Equipment JSC
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous … Read more